Insulin oral - Apollo Life SciencesAlternative Names: Insulin tablets - Apollo Life Sciences
Latest Information Update: 09 Mar 2011
At a glance
- Originator Apollo Life Sciences
- Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Type 1 diabetes mellitus; Type 2 diabetes mellitus